In mid-2015 the active ingredient naphazoline was switched from prescription to OTC, in the pharmaceutical from of naphazoline hydrochloride in ophthalmic solution in concentrations of 0.125mg/ml, 0.5mg/ml (0.05%), 1mg/ml and 1.2mg/ml, benefiting brands such as Luz Zul and Nazil Ofteno. This active ingredient is used to treat allergic conjunctivitis. The switch led to an increase in OTC eye care, which was previously dominated by artificial tears and products to help with eye lubrication.
Euromonitor International's Eye Care in Colombia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.
Product coverage: Allergy Eye Care, Standard Eye Care.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Get a detailed picture of the Eye Care market;
Pinpoint growth sectors and identify factors driving change;
Understand the competitive environment, the market’s major players and leading brands;
Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.